EP13.07-10 A Study of Sintilimab Combined with Anlotinib and chemotherapy as Second-Line or Later Therapy in Extensive-Disease Small Cell Lung Cancer

Z. Wang,X. Han, J. Guo,L. Li,Y. Huang, L. Ma,M. Zhao

Journal of Thoracic Oncology(2023)

引用 0|浏览11
暂无评分
关键词
sintilimab combined,cell lung cancer,lung cancer,anlotinib,second-line,extensive-disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要